Cart  

No products

Shipping $0.00
Tax $0.00
Total $0.00

Prices are tax included

Check out

CRI Newsletter

Categories

 

Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017

Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017

CRI predicts that the production capacity of the industry will expand in the future. Furthermore, the development strategy of most enterprises is transversely enriching product varieties and vertically developing towards the upstream and downstream.

More details


$2,200.00 tax incl.

Loyalty program By buying this product you can collect up to 110 loyalty points. Your cart will total 110 points that can be converted into a voucher of $110.00.


Description

Table of Contents | Selected Charts

 

In Chinese market, there are mainly three categories of in-vitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of in-vitro diagnostic reagent market in total in 2012.

 

Global in-vitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share. In 2011, the market scale of global in-vitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets.

 

In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprises concentrate in the biochemical reagent field, so the competition is mainly in the biochemical field. Both the supply and demand of immune and molecular products are prosperous. In addition to immune reagents, markets of other diagnostic reagents are mainly occupied by Chinese domestic enterprises. Although China in-vitro diagnostic reagent industry started late and its scale is limited, it grows rapidly. In 2012, the market scale reached CNY 13.6 billion, among which immune diagnostic reagents, biochemical diagnostic reagents and molecular diagnostic reagents ranked among the top.

 

According to the investigation of CRI, the production line utilization of various in-vitro diagnostic reagent manufacturers is universally high. Therefore, CRI predicts that the production capacity of the industry will expand in the future. Furthermore, the development strategy of most enterprises is transversely enriching product varieties and vertically developing towards the upstream and downstream.

 

China's population accounts for more than 20% of the world's population, while the market share of in-vitro diagnostics is less than 5% of the world's; in 2012, the annual consumption per capita of China's in-vitro diagnostic products was less than USD 2, while that of developed countries reached USD 25 to USD 30. Therefore, there is a wide growth space for China's in-vitro diagnostics. CRI predicts that the growth rate of the market scale of China's in-vitro diagnostics will be markedly higher than the global average level and the CAGR will maintain over 15% from 2013 to 2017. By 2017, the market scale will reach CNY 30 billion, among which immune and biochemical products will continually occupy most of the market share, while the proportion of molecular products will relatively increase. During the upgrading of products in the future and the process of domestic substitution, the industry concentration rate will grow.

 

Before 2003, medium and high-end diagnostic products were monopolized by imports, but the improvement of domestic diagnostic reagent production levels has significantly changed the market pattern. In the primary market, the share of domestically made reagents is increasing gradually, while foreign enterprises still dominate the instrument market. Currently, Chinese domestic enterprises are gradually expanding from reagents to instruments and occupying the market through advantages of instruments to promote the sales of reagents. As diagnostic services are charged by project, medical institutions prefer cheaper domestically produced reagents as long as the quality is ensured. The costs saved can directly become revenue of the institutions. Currently, biochemical and enzyme immunoassay diagnostics continue to dominate the market of diagnostic reagents.

 

Readers can obtain the following information or more through this report:

-Status of Global and China In-vitro Diagnostic Reagents

-Governmental Policies on China In-vitro Diagnostic Reagent Industry

-Status of Market Competition in In-vitro Diagnostic Reagent Industry

-Major In-vitro Diagnostic Reagent Manufacturers in Global and China Markets

-Forecast on the Development of In-vitro Diagnostic Reagent Industry

 

The Following Enterprises and People Are Recommended to Purchase This Report:

-In-vitro Diagnostic Reagent Manufacturers

-In-vitro Diagnostic Reagent Trading Enterprises

-Medical Institutions

-Research Institutions/Investors Concerned About In-vitro Diagnostic Reagent Industry

 China's OTC Drug Market

Table of Contents

Chapter 1 Overview on In-vitro Diagnostic Reagent Industry

1.1 Definition

1.2 Classification

1.2.1 Classification by Diagnosis Principles or Diagnosis Methods

1.2.2 China-featured Classification Methods

1.3 Industry Chain of In-vitro Diagnostic Reagents

 

Chapter 2 Global In-vitro Diagnostic Reagent Industry, 2011-2013

2.1 Industry Overview

2.1.1 Development Process

2.1.2 Competition Pattern

2.1. 3 Market Scale

2.2 Major Manufacturers of Global In-vitro Diagnostic Reagent Industry

2.2.1 F. Hoffmann-La Roche, Ltd.

2.2.2 Siemens AG

2.2.3 Abbott Laboratories

 

Chapter 3 Development Environment of China In-vitro Diagnostic Reagent Industry, 2011-2013

3.1 Economic Environment

3.2 Policy Environment

3.2.1 Competent Government Authorities

3.2.2 Policies on Enterprise Establishment

3.2.3 Policies on Production

3.2.4 Policies on Circulation

 

Chapter 4 Operation Status of China Diagnostic Reagent Industry, 2008-2012

4.1 Development Process of China In-vitro Diagnostic Reagent Industry16

4.2 Barriers to Entry

4.2.1 Policy Barriers

4. 2.2 Technological Barriers

4.2.3 Sales Channel Barriers

4.3 Supply Status of China In-vitro Diagnostic Reagent Industry

4.3.1 Major Manufacturers

4.3.2 Market Supply

4. 3. 3 Status of Market Competition

4.3.4 Status of Product Import and Export

4.4 Market Demand for In-vitro Diagnostic Reagents in China

4.4.1 Overall Market Scale

4.4.2 Market Scale of Biochemical Diagnostic Reagents

4.4.3 Market Scale of Immune Diagnostic Reagents

4.4.4 Market Scale of Molecular Diagnostic Reagents

 

Chapter 5 Top 5 Enterprises of China's In-vitro Diagnostic Reagent Industry, 2011-2013

5.1 Shanghai Kehua Bio-engineering Co., Ltd.

5.2 Shanghai Fosun Pharmaceutical Co., Ltd.

5.3 DAAN Gene Co., Ltd. of Sun Yat-sen University

5.4 Beijing Leadman Biochemistry Co., Ltd.

5.5 BioSino Bio-technology and Science Inc.

 

Chapter 6 Prospect of China In-vitro Diagnostic Reagent Industry, 2013-2017

6.1 Forecast on Supply

6.2 Forecast on Market Demand

6.2. 1 Industry Development Trend

6.2.2 Forecast on  Overall Market Scale

6.2.3 Forecast on Segmented Market Scale

6.3 Forecast on Market Competition

6.3.1 Forecast on Popular Products

6.3.2 Forecast on Competition Pattern

 

Selected Charts

Chart Sales Value of Global Major In-vitro Diagnostics Enterprises, 2012

Chart Market Scale of Global In-vitro Diagnostics Industry, 2007-2012

Chart Market Distribution of Global In-vitro Diagnostics Industry, 2012

Chart Forecast on Market Scale of China In-vitro Diagnostic Reagents Industry, 2013-2017

Chart Sales Value of In-vitro Diagnostics Products of Roche Diagnostics Department, 2008-2012

Chart Major In-vitro Diagnostic Reagent Products of Roche on China Market

Chart Sales Value of In-vitro Diagnostics Products of Siemens Diagnostic Business Group, 2008-2012

Chart Sales Value of In-vitro Diagnostics Products of Abbott Diagnostics Department, 2008-2012

Chart Major Laws and Regulations on China's In-vitro Diagnostic Reagent Industry

Chart Major Manufacturers of In-vitro Diagnostic Reagents in China

Chart Market Scale of China In-vitro Diagnostic Reagents, 2007-2012 

Chart Market Segmentation of China In-vitro Diagnostic Reagents, 2012

Chart Market Scale of China Biochemical In-vitro Diagnostic Reagents, 2007-2012

Chart Market Scale of China Immune In-vitro Diagnostic Reagents, 2007-2012

Chart Market Scale of China Molecular In-vitro Diagnostic Reagents, 2007-2012

Chart Major In-vitro Diagnostic Reagent Products of Shanghai Kehua Bio-engineering Co., Ltd.

Chart Sales Value of Diagnostic Reagent Products of Shanghai Kehua Bio-engineering Co., Ltd., 2008-2012

Chart Diagnostic Reagent Product Structure of Shanghai Kehua Bio-engineering Co., Ltd., 2012-2013

Chart Major In-vitro Diagnostic Reagent Products of Beijing Leadman Biochemistry Co., Ltd.

Chart Sales Value of Diagnostic Reagent Products of Beijing Leadman Biochemistry Co., Ltd., 2008-2012 

Chart Forecast on Market Scale of China In-vitro Diagnostic Reagents, 2013-2017

Chart Forecast on Market Scale of China Biochemical In-vitro Diagnostic Reagents, 2013-2017

Chart Forecast on Market Scale of China Immune In-vitro Diagnostic Reagents, 2013-2017

 

  • Charts: 30
  • Geographical Area: China
  • Pages: 50
  • Publication Date: 2013-8-1
  • Publication Frequency: Yearly
  • Publisher: CRI

PayPal